-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Anti-tumor necrosis factor (anti-TNF) monoclonal antibody is an effective and mature treatment method for alleviating Crohn's disease and ulcerative colitis
Ulcerative colitis immunity
The occurrence of ADA is related to the decrease of serum drug level, the decrease of curative effect and the failure of treatment
Recently, it has been noted that there is a correlation between the composition of the gut microbiota and the response to anti-TNF treatments
antibiotic
The researchers analyzed data from epi-IIRN (the epidemiology group at the core of the Israeli IBD research), which is a national register of all IBD patients in Israel
Kaplan-Meier curve diagram of the cumulative risk of ADA development caused by the use of different types of antibiotics
The Kaplan-Meier curve of the cumulative risk of ADA development caused by the use of different types of antibiotics The Kaplan-Meier curve of the cumulative risk of ADA development caused by the use of different types of antibioticsThe results showed that among the 1946 eligible patients, the median follow-up time from the start of treatment was 651 days, and 363 were ADA positive
Patients taking cephalosporins (HR=1.
Therefore, this study shows that the production of ADA is related to the composition of microorganisms
The production of ADA is related to the composition of microorganisms.
Original source:
Original source:Yuri Gorelik et al.
Yuri Gorelik et al.
Leave a message here